CMS coverage policies restrict patient access to important treatment options for Alzheimer’s disease

There’s been a lot of discussion this year about the Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) for new Alzheimer’s treatments finalized earlier this year in...
Read More
Myth vs. Fact: The Senate’s latest price setting proposal

The narratives being built around the Senate’s latest price setting proposal frame it as a bill intended to lower drug prices for patients and address rising inflation. But those narratives aren’t...
Read More
The Senate’s latest price setting proposal will undermine U.S. economic growth

Last week, we examined ways the latest drug pricing proposal will undermine patient access to medicines, American medical innovation and our health care system as a whole. But there is another...
Read More
Celebrating Medicare’s 57th anniversary

In case you missed it, Saturday, July 30, marked the anniversary of Medicare. For 57 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans...
Read More
The Senate’s latest price setting proposal will undermine: Our health care system

Members of Congress continue to push a misguided drug pricing proposal under the guise of negotiation as part of the reconciliation package. This proposal is nothing short of government price setting...
Read More
New research shows competition driven by biosimilars helps control costs in Part B

Discussions about spending in Medicare Part B, including a recent report from the Medicare Payment Advisory Commission, or MedPAC, too often overlook how competition between medicines drives down the...
Read More
Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients

As policymakers race to pass government price setting policies, it’s important to examine true public sentiment around such proposals. Voters have made clear that they do not support policies such as...
Read More
CMS coverage decision restricts access to treatments for Alzheimer’s disease

This year’s Alzheimer’s and Brain Awareness Month offers an important opportunity to remember the severe toll that Alzheimer’s takes on patients and family caregivers. Unfortunately, this year also...
Read More
The Centers for Medicare & Medicaid Services (CMS) recently released their National Health Expenditure (NHE) projections of health care spending in the United States through 2030. While these data...
Read More
Part D 101: Three charts show how the Medicare Part D program could be improved to work better for seniors and people with disabilities

In yesterday’s post, we learned how Medicare Part D works for seniors and people with disabilities. Unfortunately, Part D beneficiaries are increasingly facing higher out-of-pocket costs for the...
Read More